Image credit: Eat Just

Brief: Eat Just targeting IPO at valuation of ‘at least $3bn,’ says investor

June 30, 2021

Why it matters:

Attempting to set itself apart from the competition, Eat Just has pursued protein product development in both the plant-based and cell-cultured arenas. Initially grabbing headlines for its mung bean-based egg substitute JUST Egg, the company claimed a world-first in November last year when regulators in Singapore approved its GOOD Meat cell-cultured chicken product for sale to the public.

Speaking to AFN recently, Eat Just co-founder and CEO Josh Tetrick said that the company would “definitely go public at some point,” though he added that its immediate priorities would be to secure further regulatory clearances around the world and convince more customers of the benefits of cultivated meat.

Join the Newsletter

Get the latest news & research from AFN and AgFunder in your inbox.

Share on email
Share on twitter
Share on facebook
Share on linkedin
Share on reddit
Share on whatsapp
Share on skype
Join the Newsletter
Get the latest news and research from AFN & AgFunder in your inbox.

Follow us:

Join Newsletter